Abstract:Copper complexes are considered as potential candidates for anticancer therapy and medical applications. In this paper, three new Cu(II) complexes, [Cu(IPY)2](ClO4)2·H2O (CuI1), [Cu(IPY)(L-Phe)H2O]ClO4·0.5H2O (CuI2) and [Cu(IPY)(L-Val)H2O]ClO4 (CuI3) (where IPY = 2-(1H-imidazol-2-yl)pyridine, L-Phe = L-phenylalanine, L-Val = L-valine), with good amphipathic properties were synthesized and characterized. The single crystal X-ray diffraction results revealed that CuI1 was four-coordinated, while CuI2 and CuI3 both adopted a five-coordinated tetragonal pyramidal configuration. Multi-spectral methods, viscosity experiment and molecular docking technique showed that three complexes interacted with DNA through insertion. The results of the gel electrophoresis experiments indicated that DNA was oxidatively cleaved by all the complexes in a concentration-dependent manner. Moreover, singlet oxygen (1O2), hydrogen peroxide (H2O2) and superoxide anion radicals (·O2−) were associated with oxidative cleavage of DNA. All the complexes also had good binding affinity with human serum albumin (HSA). The MB degradation assay revealed that all complexes could react with H2O2 to form ·OH through Fenton-like processes. The complexes displayed good antiproliferative activity against the tested human cancer cells in vitro, including cervical carcinoma cells (HeLa), liver cancer cells (HepG2 and BEL-7402) and gastric adenocarcinoma cells (SGC-7901), but showed lower toxicity to normal liver cells (LO2). The anticancer mechanism research revealed that CuI1, CuI2 and CuI3 arrested the cell cycle at S phase, elevated intracellular reactive oxygen species (ROS) levels and induced loss of mitochondrial membrane potential (MMP). The results indicated that these Cu(II) complexes could induce DNA damage and ROS-mediated mitochondrial dysfunction, leading to cancer cell apoptosis. Our work provided a theoretical basis for the design of new low-toxic and highly efficient anticancer Cu(II) complexes by incorporating biological metabolites and aromatic heterocycle ligands.

Synthesis, structure, DNA-binding properties and cytotoxic activities of a new one-dimensional polymeric copper(II) complex with N-benzoate-N′-[3-(2- hydroxyl-ethylammino)propyl]oxamide as ligand

SYNTHESIS AND CRYSTAL STRUCTURE OF A BINUCLEAR COPPER (II) COMPLEX BRIDGED BY OXAMIDATO, Cu2(μ-CIS-OXPN)(PHEN)(NO3)2

Two Novel Copper Complexes of 2,2′-Bipyridine: Evaluation of the DNA Binding and Cytotoxic Activity

Synthesis, characterization, DNA interaction and cytotoxic activities of copper complexes with ethyl 2-[bis(2-pyridylmethyl)amino]propionate.

Interaction with DNA and Different Effect on the Nucleus of Cancer Cells for Copper(ii) Complexes of N-benzyl Di(pyridylmethyl)amine

Synthesis, structure, and biological properties of Cu(II) complexes based on diimine ligands

Synthesis, Magnetic Properties, DNA Binding and Cleavage Activity of a New Oxalato Bridged Copper(ii) Complex

Synthesis, Crystal Structure, DNA-binding Properties, Cytotoxic and Antioxidation Activities of Several Ternary Copper(ii) Complexes with a New Reduced Schiff Base Ligand

Synthesis, Crystal Structure, Dna Cleavage Properties, and Protein Binding Activities of an Unsymmetrical Dinuclear Copper( Ii) Complex

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Synthesis, structure, DNA binding, and cleavage activity of two copper(II) complexes

Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

A polymeric copper complex based on a pyrazole derivative: Synthesis, spectroscopic, X‐ray, and biological activity studies

Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand

A Novel Cytotoxic Ternary Copper(ii) Complex of 1,10-Phenanthroline and L-threonine with DNA Nuclease Activity.

DNA-binding and anticancer properties of two mononuclear copper-pyridine complexes

Synthesis, Crystal Structure and Property of A Binuclear Copper Complex [cu2l2(pht)(2)](2)center Dot H2o

Synthesis, Crystal Structures, Photophysical Properties and Antibacterial Activities of Copper(II) Complex Derived from 4-Chloro-2-{[(2,6-dimethylphenyl)imino]methyl}phenol

Dna Binding, Oxidative Dna Cleavage, Cytotoxicity, and Apoptosis-Inducing Activity of Copper(Ii) Complexes with 1,4-Tpbd (N,N,N ',N '-Tetrakis(2-yridylmethyl)benzene-1,4-diamine) Ligand